These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 35241226)

  • 21. Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial.
    Blondon M; Cereghetti S; Pugin J; Marti C; Darbellay Farhoumand P; Reny JL; Calmy A; Combescure C; Mazzolai L; Pantet O; Ltaief Z; Méan M; Manzocchi Besson S; Jeanneret S; Stricker H; Robert-Ebadi H; Fontana P; Righini M; Casini A
    Res Pract Thromb Haemost; 2022 May; 6(4):e12712. PubMed ID: 35599701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous and arterial thrombosis in COVID-19: An updated narrative review.
    Duhailib ZA; Oczkowski S; Polok K; Fronczek J; Szczeklik W; Piticaru J; Mammen MJ; Alshamsi F; Eikelboom J; Belley-Cote E; Alhazzani W
    J Infect Public Health; 2022 Jun; 15(6):689-702. PubMed ID: 35643053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic complications in 2928 patients with COVID-19 treated in intensive care: a systematic review.
    Jenner WJ; Kanji R; Mirsadraee S; Gue YX; Price S; Prasad S; Gorog DA
    J Thromb Thrombolysis; 2021 Apr; 51(3):595-607. PubMed ID: 33586113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apixaban: A Review in Venous Thromboembolism.
    Greig SL; Garnock-Jones KP
    Drugs; 2016 Oct; 76(15):1493-1504. PubMed ID: 27653758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cov-hep study: heparin in standard anticoagulation based on citrate for continuous veno-venous hemodialysis in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Lins PRG; de Albuquerque CCC; Assis CF; Rodrigues BCD; E Siqueira Campos BP; de Oliveira Valle E; Cabrera CPS; de Oliveira Gois J; Segura GC; Strufaldi FL; Mainardes LC; Ribeiro RG; Via Reque Cortes DDP; Lutf LG; de Oliveira MFA; Sales GTM; Smolentzov I; Reichert BV; Andrade L; Seabra VF; Rodrigues CE
    Trials; 2020 Nov; 21(1):920. PubMed ID: 33176886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation prescribing patterns in patients with cancer.
    Xiang E; Ahuja T; Raco V; Cirrone F; Green D; Papadopoulos J
    J Thromb Thrombolysis; 2018 Jan; 45(1):89-98. PubMed ID: 29052104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
    Huang J; Cao Y; Liao C; Wu L; Gao F
    Thromb Haemost; 2011 Feb; 105(2):245-53. PubMed ID: 20941455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study.
    Worth H; Helmlinger K; Raj R; Heidel E; Lands R
    Clin Appl Thromb Hemost; 2021; 27():10760296211053315. PubMed ID: 34786969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital-admitted COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    Rauniyar R; Kuikel S; Mishra A; Rauniyar R; Yadav S; Thapaliya S; Nepal AS; Rauniyar R
    Clin Respir J; 2023 Feb; 17(2):73-79. PubMed ID: 36572657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dialysis circuit clotting in critically ill patients with COVID-19 infection.
    Khoo BZE; Lim RS; See YP; Yeo SC
    BMC Nephrol; 2021 Apr; 22(1):141. PubMed ID: 33879086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-Analysis Comparing the Efficacy, Safety, and Cost-Benefit of Direct Acting Oral Anticoagulants Versus Enoxaparin Thromboprophylaxis to Prevent Venous Thromboembolism Among Hospitalized Patients.
    Bhalla V; Abdel-Latif A; Bhalla M; Ziada K; Williams MV; Smyth SS
    Am J Cardiol; 2018 Oct; 122(7):1236-1243. PubMed ID: 30082040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation Before Hospitalization Is a Potential Protective Factor for COVID-19: Insight From a French Multicenter Cohort Study.
    Chocron R; Galand V; Cellier J; Gendron N; Pommier T; Bory O; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Geneste L; Schmeltz A; Panagides V; Philippe A; Marsou W; Ben Abdallah I; Deney A; El Batti S; Attou S; Juvin P; Delmotte T; Messas E; Pezel T; Planquette B; Duceau B; Gaussem P; Sutter W; Sanchez O; Waldman V; Diehl JL; Mirault T; Bonnet G; Cohen A; Smadja DM;
    J Am Heart Assoc; 2021 Apr; 10(8):e018624. PubMed ID: 33550816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
    Muthiah A; Ohnigian S; Reagan JL; Hsu A
    R I Med J (2013); 2022 Aug; 105(6):36-40. PubMed ID: 35881999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
    Klein HH
    Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apixaban versus enoxaparin in medically ill patients.
    Yang ZY; Mao C; Jin-Ling TJ
    N Engl J Med; 2012 Feb; 366(8):767; author reply 767-8. PubMed ID: 22356339
    [No Abstract]   [Full Text] [Related]  

  • 36. Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations-State-of-the-Art.
    Dimakakos E; Gomatou G; Catalano M; Olinic DM; Spyropoulos AC; Falanga A; Maraveyas A; Liew A; Schulman S; Belch J; Gerotziafas G; Marschang P; Cosmi B; Spaak J; Syrigos K;
    Anticancer Res; 2022 Jul; 42(7):3261-3274. PubMed ID: 35790272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.
    Nadkarni GN; Lala A; Bagiella E; Chang HL; Moreno PR; Pujadas E; Arvind V; Bose S; Charney AW; Chen MD; Cordon-Cardo C; Dunn AS; Farkouh ME; Glicksberg BS; Kia A; Kohli-Seth R; Levin MA; Timsina P; Zhao S; Fayad ZA; Fuster V
    J Am Coll Cardiol; 2020 Oct; 76(16):1815-1826. PubMed ID: 32860872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
    Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
    J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
    Squizzato A; Lussana F; Cattaneo M
    Thromb Haemost; 2015 Aug; 114(2):237-44. PubMed ID: 25946985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.